CRISPR Therapeutics AG
NASDAQ:CRSP
CRISPR Therapeutics AG
NASDAQ:CRSP
Price:
38.95
USD
0.36%
Market Closed
Market Cap:
3.3B
USD
P/S
Price to Sales
Price to Sales
89.5
Current
26.2
Median
6.5
Industry
Higher
than median
Higher
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=89.5
Market Cap
/
3.3B USD
Revenue
37.3m USD
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
58.9
2-Years Forward
P/S
15.4
3-Years Forward
P/S
6.8
You don't have any saved screeners yet
